Mode
Text Size
Log in / Sign up
N/A N=304 Randomized Treatment

Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users

HIV · Opioid Dependence

Enrolled (actual)
304
Serious AEs
0.0%
Results posted
Feb 2014
Primary outcome: Primary: Demonstrated Drug Risk Reduction Skills (0-100%) — 40.60; 42.75 Percentage of correct steps

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Community-friendly Health Recovery Program (Behavioral); Time-and-Attention-Matched Control Condition (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Connecticut
Primary completion
May 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Demonstrated Drug Risk Reduction Skills (0-100%)
72.61; 63.63
PRIMARY
Demonstrated Drug Risk Reduction Skills (0-100%)
72.61; 63.63
PRIMARY
Demonstrated Drug Risk Reduction Skills (0-100%)
72.61; 63.63
PRIMARY
Demonstrated Drug Risk Reduction Skills (0-100%)
72.61; 63.63
PRIMARY
Demonstrated Drug Risk Reduction Skills (0-100%)
72.61; 63.63
PRIMARY
Safer Drug Use (0-4)
3.87; 3.85
PRIMARY
Safer Drug Use (0-4)
3.87; 3.85
PRIMARY
Safer Drug Use (0-4)
3.87; 3.85
PRIMARY
Safer Drug Use (0-4)
3.87; 3.85
PRIMARY
Safer Drug Use (0-4)
3.87; 3.85
PRIMARY
Drug-related HIV-risk Reduction Knowledge (0-1)
0.98; 0.96
PRIMARY
Drug-related HIV-risk Reduction Knowledge (0-1)
0.98; 0.96
PRIMARY
Drug-related HIV-risk Reduction Knowledge (0-1)
0.98; 0.96
PRIMARY
Drug-related HIV-risk Reduction Knowledge (0-1)
0.98; 0.96
PRIMARY
Drug-related HIV-risk Reduction Knowledge (0-1)
0.98; 0.96
PRIMARY
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
4.88; 4.92
PRIMARY
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
4.88; 4.92
PRIMARY
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
4.88; 4.92
PRIMARY
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
4.88; 4.92
PRIMARY
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
4.88; 4.92
PRIMARY
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
4.63; 4.75
PRIMARY
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
4.63; 4.75
PRIMARY
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
4.63; 4.75
PRIMARY
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
4.63; 4.75
PRIMARY
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
4.63; 4.75
PRIMARY
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
4.38; 4.52
PRIMARY
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
4.38; 4.52
PRIMARY
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
4.38; 4.52
PRIMARY
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
4.38; 4.52
PRIMARY
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
4.38; 4.52
PRIMARY
Female Condom Skills (0-100%)
83.37; 82.19
PRIMARY
Female Condom Skills (0-100%)
83.37; 82.19
PRIMARY
Female Condom Skills (0-100%)
83.37; 82.19
PRIMARY
Female Condom Skills (0-100%)
83.37; 82.19
PRIMARY
Female Condom Skills (0-100%)
83.37; 82.19
PRIMARY
Male Condom Skills (0-100%)
86.70; 85.95
PRIMARY
Male Condom Skills (0-100%)
86.70; 85.95
PRIMARY
Male Condom Skills (0-100%)
86.70; 85.95
PRIMARY
Male Condom Skills (0-100%)
86.70; 85.95
PRIMARY
Male Condom Skills (0-100%)
86.70; 85.95
PRIMARY
Condom Use (0-4)
3.73; 3.83
PRIMARY
Condom Use (0-4)
3.73; 3.83
PRIMARY
Condom Use (0-4)
3.73; 3.83
PRIMARY
Condom Use (0-4)
3.73; 3.83
PRIMARY
Condom Use (0-4)
3.73; 3.83
PRIMARY
Sex-related HIV-risk Reduction Knowledge (0-1)
0.98; 0.99
PRIMARY
Sex-related HIV-risk Reduction Knowledge (0-1)
0.98; 0.99
PRIMARY
Sex-related HIV-risk Reduction Knowledge (0-1)
0.98; 0.99
PRIMARY
Sex-related HIV-risk Reduction Knowledge (0-1)
0.98; 0.99
PRIMARY
Sex-related HIV-risk Reduction Knowledge (0-1)
0.98; 0.99
PRIMARY
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
4.21; 4.22
PRIMARY
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
4.21; 4.22
PRIMARY
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
4.21; 4.22
PRIMARY
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
4.21; 4.22
PRIMARY
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
4.21; 4.22
PRIMARY
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
4.57; 4.70
PRIMARY
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
4.57; 4.70
PRIMARY
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
4.57; 4.70
PRIMARY
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
4.57; 4.70
PRIMARY
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
4.57; 4.70
PRIMARY
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
4.57; 4.70
PRIMARY
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
4.57; 4.70
PRIMARY
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
4.57; 4.70
PRIMARY
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
4.57; 4.70
PRIMARY
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
4.57; 4.70

Summary

To conduct a randomized clinical trial (RCT) of a community-friendly behavioral intervention designed to reduce HIV risk behavior among injection drug users (IDUs) in drug treatment by comparing risk-behavior outcomes of four weekly intervention sessions with a time-and-attention-matched control condition.

Eligibility Criteria

Inclusion Criteria

  • At least 18 years of age
  • Opioid-dependent and seeking methadone maintenance treatment
  • Report drug- or sex-related HIV risk behavior in previous 6 months
  • Able to read and understand the questionnaires, Audio Computer Assisted Self Interview (ACASI), and consent form
  • Available for the full duration of the study with no anticipated circumstances impeding participation (e.g., jail term)
  • Not actively suicidal, homicidal, or psychotic as assessed by trained research staff under the supervision of a licensed clinical psychologist

Exclusion Criteria

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01741350). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search